Match!
G. Lorimier
45Publications
18H-index
2,615Citations
Publications 45
Newest
#1G. LorimierH-Index: 18
#2V. SeegersH-Index: 1
Last.Veronique Guerin-MeyerH-Index: 8
view all 13 authors...
Abstract Objective To assess the effectiveness of prolonged perioperative thoracic epidural analgesia (PEA) on long term survival of patients who underwent a complete cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases (CPM). Background Grade III-IV morbidity affects long term outcomes after CRS and HIPEC. As compared with opioid administered via patient-controlled analgesia (PCA), PEA reduces morbidity. Method From 2005 to 2016,...
#1Sanket Mehta (Saifee Hospital)H-Index: 4
#2Lilian SchwarzH-Index: 13
Last.David L. Bartlett (University of Pittsburgh)H-Index: 48
view all 86 authors...
Abstract Introduction Peritoneal metastasis (PM) of hepatocellular carcinoma (HCC) without distant spread are rare. The related prognosis is poor without standard treatment available. The role of cytoreduction surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is poorly documented. Methods An international multicentric cohort was constituted by retrospective analysis of 21 patients undergoing CRS/HIPEC for PM of HCC between 1992 and 2016 from 10 reference centers of PSOGI. Data ...
#1I. Amblard (University of Lyon)H-Index: 1
#2Frederic Mercier (UdeM: Université de Montréal)H-Index: 2
Last.Pompiliu PisoH-Index: 35
view all 83 authors...
Abstract Background Peritoneal metastasis from biliary carcinoma (PMC) is associated with poor prognosis when treated with chemotherapy. Objective To evaluate the impact on survival of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), and compare with conventional palliative chemotherapy for patients with PMC. Material and methods A prospective multicenter international database was retrospectively searched to identify all patients with PMC treated with a potenti...
#1F. QuenetH-Index: 23
#2D. EliasH-Index: 80
Last.G. LorimierH-Index: 18
view all 17 authors...
LBA3503Background: Promising results have been obtained during the last decade using cytoreductive surgery (CRS) plus HIPEC for selected patients with colorectal PC who are amenable to complete macroscopic resection. This is the first trial to evaluate the specific role of HIPEC, after CRS, for the treatment of PC of colorectal origin. Methods: Prodige 7 is a randomized phase III, multicenter trial. Patients with histologically proven and isolated PC, peritoneal cancer index (PCI) ≤25 were eligi...
418Background: Peritoneal metastasis from biliary carcinoma (PMC) is associated with poor prognosis when treated with chemotherapy. The objective was to evaluate the impact on survival of cytoreduction surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), and compare with conventional palliative chemotherapy for patients with PMC. Methods: A prospective multicenter international database was retrospectively searched to identify all patients with PMC treated with a potentially cura...
#1S. Valmary-DeganoH-Index: 3
#2P. ColpartH-Index: 1
Last.V. Verriele-BeurrierH-Index: 2
view all 98 authors...
Abstract Background Epithelioid peritoneal malignant mesothelioma (EPMM) is the most common subtype of this aggressive tumor. We compared two antibodies against PD-L1, a recent theranostic biomarker, and evaluated the prognostic value of PD-L1 expression by mesothelial and immune cells in EPMM. Methods Immunohistochemistry was performed on 45 EPMM. Clinical and pathological data were extracted from the RENAPE database. Using E1L3N and SP142 clones, inter-observer agreement, PD-L1 expression by m...
#1G. LorimierH-Index: 18
#2B. LinotH-Index: 1
Last.Olivier CapitainH-Index: 9
view all 8 authors...
Abstract Objectives This study describes the outcomes of patients with colorectal peritoneal carcinomatosis (PC) with or without liver metastases (LMs) after curative surgery combined with hyperthermic intraperitoneal chemotherapy, in order to assess prognostic factors. Background Cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) increases overall survival (OS) in patients with PC. The optimal treatment both for PC and for LMs within one surgical operation...
#1Mohammad Alyami (University of Lyon)H-Index: 5
#2P. Lundberg (University of Lyon)H-Index: 3
Last.E. ThibaudeauH-Index: 4
view all 27 authors...
Objective This study was designed to identify factors associated with morbidity and mortality in patients older than 70 years who underwent cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis (PC).
12345